| 000 | 01727 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515071348.0 | ||
| 264 | 0 | _c20070815 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1535-7163 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-07-0067 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIkezoe, Takayuki | |
| 245 | 0 | 0 |
_aA novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cJun 2007 |
||
| 300 |
_a1851-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aAurora Kinase A |
| 650 | 0 | 4 | _aAurora Kinases |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aDNA Primers |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xenzymology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aYang, Jing | |
| 700 | 1 | _aNishioka, Chie | |
| 700 | 1 | _aTasaka, Taizo | |
| 700 | 1 | _aTaniguchi, Ayuko | |
| 700 | 1 | _aKuwayama, Yoshio | |
| 700 | 1 | _aKomatsu, Naoki | |
| 700 | 1 | _aBandobashi, Kentaro | |
| 700 | 1 | _aTogitani, Kazuto | |
| 700 | 1 | _aKoeffler, H Phillip | |
| 700 | 1 | _aTaguchi, Hirokuni | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 6 _gno. 6 _gp. 1851-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-07-0067 _zAvailable from publisher's website |
| 999 |
_c17080767 _d17080767 |
||